High prevalence of antibiotic-resistant mycoplasma genitalium in nongonococcal urethritis: The need for routine testing and the inadequacy of current treatment options

Clinical Infectious Diseases

Volumn 58, Issue 5, 2014, Pages 631-637

  Pond, Marcus J ^a   Nori, Achyuta V ^a,b   Witney, Adam A ^a   Lopeman, Rose C ^a   Butcher, Philip D ^a   Sadiq, Syed Tariq ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

antimicrobial resistance; Mycoplasma genitalium; nongonococcal urethritis; sequence typing

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; MACROLIDE; QUINOLONE DERIVATIVE; RIBOSOME DNA; RNA 23S;

ANTIBIOTIC RESISTANCE; CHEMISTRY; DRUG EFFECTS; GENETIC VARIABILITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; URETHRITIS;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENETIC VARIATION; HUMANS; MACROLIDES; MALE; MULTILOCUS SEQUENCE TYPING; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RNA, RIBOSOMAL, 23S; URETHRITIS;

EID: 84894247045     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit752     Document Type: Article

References (30)

1. Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis 2011; 53(suppl 3):S129-42.
2. Jensen JS. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol 2004; 18:1-11.
3. Martin DH. Non-gonococcal urethritis: new views through the prism of modern molecular microbiology. Curr Infect Dis Rep 2008; 10:128-32.
4. Clinical Effectiveness Group, British Association for Sexual Health and HIV. 2007 UK national guideline on the management of nongonococcal urethritis. Updated 16 November 2012. Available at: http://www. bashh.org/documents/1955. pdf. Accessed 4 December 2012.
5. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Reports 2010; 59(RR-12):1-110.
6. Bradshaw CS, Jensen JS, Tabrizi SN, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12:1149-52.
7. Bjornelius E, Anagrius C, Bojs G, et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84:72-6.
8. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47:1546-53.
9. Ito S, Shimada Y, Yamaguchi Y, et al. Selection of Mycoplasma genitalium strains harboring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex Transm Infect 2011; 87:412-4.
10. Yew HS, Anderson T, Coughlan E, Werno A. Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis. J Clin Microbiol 2011; 49:1695-6.
11. Hamasuna R. Identification of treatment strategies for Mycoplasma genitalium-related urethritis in male patients by culturing and antimicrobial susceptibility testing. J Infect Chemother 2013; 19:1-11.
12. Jensen JS, Bjornelius E, Dohn B, Lidbrink P. Use of TaqMan 5′ nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol 2004; 42: 683-92.
13. Pillay A, Radebe F, Fehler G, Htun Y, Ballard RC. Comparison of a TaqMan-based real-time polymerase chain reaction with conventional tests for the detection of Trichomonas vaginalis. Sex Transm Infect 2007; 83:126-9.
14. Cazanave C, Charron A, Renaudin H, Bébéar C. Method comparison for molecular typing of French and Tunisian Mycoplasma genitaliumpositive specimens. J Med Microbiol 2012; 61:500-6.
15. Hjorth SV, Björnelius E, Lidbrink P, et al. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. Clin Microbiol 2006; 44:2078-83.
16. Ma L, Taylor S, Jensen JS, Myers L, Lillis R, Martin DH. Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol 2008; 8: 130.
17. Musatovova O, Baseman JB. Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium. J Clin Microbiol 2009; 47:1469-75.
18. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006; 22:2688-90.
19. Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013; 4:e61481.
20. Schwebke JR, Rompalo A, Taylor S, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens-a randomized clinical trial. Clin Infect Dis 2011; 52:163-70.
21. Manhart LE, Gillespie CW, Lowens MS, et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis 2013; 56: 934-42.
22. Shimada Y, Deguchi T, Yamaguchi Y, et al. gyrB and parE mutations in urinary Mycoplasma genitalium DNA from men with non-gonococcal urethritis. Int J Antimicrob Agents 2010; 36:477-8.
23. Yamaguchi Y, Takei M, Kishii R, Yasuda M, Deguchi T. Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium. Antimicrob Agents Chemother 2013; 57:1772-6.
24. Manhart LE, Khosropour CM, Gillespie CW, Lowens MS, Golden MRTotten PA. Treatment outcomes for persistent Mycoplasma genitalium-associated NGU: evidence of moxifloxacin treatment failures. ISSTDR, Vienna, July 2013. Oral session O02.3. STIs 2013; 89(S1): A29.
25. Le Roy C, Le Hen I, Clerc M, et al. The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. Microbiol Methods 2012; 89:193-7.
26. Twin J, Jensen JS, Bradshaw CS, et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS One 2012; 7:e35593.
27. Sadiq ST, Dave J, Butcher PD. Point-of-care antibiotic susceptibility testing for gonorrhoea: improving therapeutic options and sparing the use of cephalosporins. Sex Transm Infect 2010; 86:445-6.
28. Goldenberg SD, Finn J, Sedudzi E, White JA, Tong CY. Performance of the GeneXpert CT/NG Assay compared to that of the Aptima AC2 Assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual Aptima samples. J Clin Microbiol 2012; 50:3867-9.
29. Lewis DA, Chirwa TF, Msimang VM, Radebe FM, Kamb ML, Firnhaber CS. Urethritis/cervicitis pathogen prevalence and associated risk factors among asymptomatic HIV-infected patients in South Africa. Sex Transm Dis 2012; 39:531-6.
30. Tagg KA, Jeoffreys NJ, Couldwell DL, Donald JA, Gilbert GL. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol 2013; 51:2245-9.